These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 16916931)

  • 41. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses.
    Young A; Ngiow SF; Barkauskas DS; Sult E; Hay C; Blake SJ; Huang Q; Liu J; Takeda K; Teng MWL; Sachsenmeier K; Smyth MJ
    Cancer Cell; 2016 Sep; 30(3):391-403. PubMed ID: 27622332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine A2A receptor plays an important role in radiation-induced dermal injury.
    Perez-Aso M; Mediero A; Low YC; Levine J; Cronstein BN
    FASEB J; 2016 Jan; 30(1):457-65. PubMed ID: 26415936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage A2A Adenosine Receptors Are Essential to Protect from Progressive Kidney Injury.
    Truong LD; Trostel J; McMahan R; Chen JF; Garcia GE
    Am J Pathol; 2016 Oct; 186(10):2601-13. PubMed ID: 27520357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
    Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
    Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
    Halldner L; Adén U; Dahlberg V; Johansson B; Ledent C; Fredholm BB
    Neuropharmacology; 2004 Jun; 46(7):1008-17. PubMed ID: 15081797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A
    Zhu C; Ze S; Zhou R; Yang X; Wang H; Chai X; Fang M; Liu M; Wang Y; Lu W; Xie Q
    J Med Chem; 2023 Apr; 66(7):4734-4754. PubMed ID: 36951370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: therapeutic window and receptor subtype mechanism.
    Wang T; Xi NN; Chen Y; Shang XF; Hu Q; Chen JF; Zheng RY
    Neuropharmacology; 2014 Nov; 86():203-11. PubMed ID: 25019206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy.
    Wen X; Xiong X; Yang G; Xiao W; Hou J; Pan T; Hu Y; Zhou S
    J Control Release; 2023 Jan; 353():535-548. PubMed ID: 36481693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine A
    Atif M; Alsrhani A; Naz F; Ullah MI; Alameen AAM; Imran M; Ejaz H
    Mol Biol Rep; 2022 Nov; 49(11):10677-10687. PubMed ID: 35752699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting adenosine A
    Congreve M; Brown GA; Borodovsky A; Lamb ML
    Expert Opin Drug Discov; 2018 Nov; 13(11):997-1003. PubMed ID: 30336706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.
    Qin Z; Schwartzkopff J; Pradera F; Kammertoens T; Seliger B; Pircher H; Blankenstein T
    Cancer Res; 2003 Jul; 63(14):4095-100. PubMed ID: 12874012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.
    Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA
    eNeuro; 2018; 5(6):. PubMed ID: 30627646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine A
    Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanistic Justifications of Systemic Therapeutic Oxygenation of Tumors to Weaken the Hypoxia Inducible Factor 1α-Mediated Immunosuppression.
    Hatfield S; Veszeleiova K; Steingold J; Sethuraman J; Sitkovsky M
    Adv Exp Med Biol; 2019; 1136():113-121. PubMed ID: 31201720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response.
    Sidders B; Zhang P; Goodwin K; O'Connor G; Russell DL; Borodovsky A; Armenia J; McEwen R; Linghu B; Bendell JC; Bauer TM; Patel MR; Falchook GS; Merchant M; Pouliot G; Barrett JC; Dry JR; Woessner R; Sachsenmeier K
    Clin Cancer Res; 2020 May; 26(9):2176-2187. PubMed ID: 31953314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting the Negative Feedback of Adenosine-A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy.
    Liu Y; Liu Y; Xu D; Zang J; Zheng X; Zhao Y; Li Y; He R; Ruan S; Dong H; Gu J; Yang Y; Cheng Q; Li Y
    Adv Sci (Weinh); 2022 May; 9(14):e2104182. PubMed ID: 35306759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.
    Kaster MP; Machado NJ; Silva HB; Nunes A; Ardais AP; Santana M; Baqi Y; Müller CE; Rodrigues AL; Porciúncula LO; Chen JF; Tomé ÂR; Agostinho P; Canas PM; Cunha RA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7833-8. PubMed ID: 26056314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
    Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
    J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenosine A
    Ran H; Yuan J; Huang J; Wang J; Chen K; Zhou Z
    Transl Stroke Res; 2020 Oct; 11(5):1028-1040. PubMed ID: 32394183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.